CDAK Stock Price, News & Analysis

CDAK NASDAQ

Company Description

CDAK (NASDAQ: CDAK) is a publicly traded biological product (except diagnostic) manufacturing company in the Manufacturing sector.

CDAK stock has declined 99.2% over the past year.

This page provides a comprehensive overview of CDAK stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-99.18%

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

CDAK (CDAK) stock. Over the past 12 months, the stock has lost 99.2%.

Latest News

View All

March 27, 2023

-56.70%

Codiak BioSciences to Pursue Asset Sale through Voluntary Chapter 11 Process

November 28, 2022

-1.34%

Codiak BioSciences to Participate 5th Annual Evercore ISI HealthCONx Conference

conferences

November 10, 2022

+7.94%

Codiak Presents Preclinical Data on exoASO™-STAT6 and exoASO™-C/EBPβ Programs at the Society for Immunotherapy of Cancer (SITC) 2022 Annual Meeting

clinical trial

November 3, 2022

-13.49%

Codiak BioSciences Reports Third Quarter 2022 Financial Results and Operational Progress

earnings

October 12, 2022

-1.47%

Codiak Presents Preclinical Data Demonstrating its Pan Beta-Coronavirus Vaccine Elicits Broad Protective Immunity Against Known Variants of SARS-CoV-2 and Related Sarbecoviruses

clinical trial

October 5, 2022

-8.83%

Codiak to Present New Preclinical Data Demonstrating Potent Monotherapy Activity of Two Engineered Exosome Intravenous Candidates Targeting Macrophages

conferences clinical trial

CDAK has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 8 with negative movement. Key topics include conferences, clinical trial, earnings, offering. View all CDAK news →

SEC Filings

View All

No SEC filings available for CDAK.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

CDAK Company Profile & Sector Positioning

CDAK (CDAK) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.